...ALTANA Aktiengesellschaft engages in the development, manufacture, and marketing of pharmaceutical and chemical products for various applications worldwide. It operates in two segments, Pharmaceuticals and Chemicals. The Pharmaceuticals division develops therapeutic products primarily for the treatment of gastrointestinal and respiratory diseases. Its primary product candidate, Pantoprazole is a proton pump inhibitor for the treatment of ulcers and reflux disease. This division also offers Ciclesonide for the treatment of asthma, as a metered dose inhaler; develops Roflumilast, a drug candidate for the treatment of asthma and chronic obstructive pulmonary diseases; imaging reagents; and over -the-counter drugs comprising gastrointestinal drugs, pain killers, tonics, and vitamins. The Chemicals division offers various specialty chemicals, including additives and measuring instruments, metallic effect pigments and printing inks, coatings and sealing compounds, and electrical...

Source: LIFE SCIENCE ANALYTICS
Company: ALTANA
Geographic Regions: EUROPE, GERMANY, WESTERN EUROPE REGION

Enter the keyword(s) which you would like to search for within this document and click "Search"

 

 TF Market Research
TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.